Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker-Reference-Cited by-同舟云学术

Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker

Published:2017-01-31 Issue:3 Volume:60 Page:1060-1075
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Corte James R.¹^ORCID,Fang Tianan¹,Osuna Honey¹,Pinto Donald J. P.¹,Rossi Karen A.¹,Myers Joseph E.¹,Sheriff Steven¹,Lou Zhen¹,Zheng Joanna J.¹,Harper Timothy W.¹,Bozarth Jeffrey M.¹,Wu Yiming¹,Luettgen Joseph M.¹,Seiffert Dietmar A.¹,Decicco Carl P.¹,Wexler Ruth R.¹,Quan Mimi L.¹

Affiliation:

1. Research and Development, Bristol-Myers Squibb Company, P.O. Box 5400, Princeton, New Jersey 08543, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01460

Reference72 articles.

1. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

2. Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants

3. How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation